Old Web
English
Sign In
Acemap
>
Paper
>
Novel Second-Generation Rexinoid Reduces Cancer Cell Stemness in Human Neuroblastoma Patient-Derived Xenografts
Novel Second-Generation Rexinoid Reduces Cancer Cell Stemness in Human Neuroblastoma Patient-Derived Xenografts
2020
Raoud Marayati
Adele P. Williams
Laura V. Bownes
Colin H. Quinn
Venkatram R. Atigadda
Jerry E. Stewart
Jamie M. Aye
Karina J. Yoon
Elizabeth A. Beierle
Keywords:
Neuroblastoma
Cancer research
Cancer cell
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]